Detalles de la búsqueda
1.
Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.
Cancer Sci
; 114(7): 2774-2786, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014183
2.
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study.
Oncologist
; 27(4): 253-e312, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380726
3.
Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis.
BMC Cancer
; 21(1): 1308, 2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34876060
4.
A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Med Sci Monit
; 26: e924269, 2020 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32613949
5.
Clinical and Cancer-Related Predictors for Venous Thromboembolism in Cancer Patients Presenting to the Emergency Department.
J Emerg Med
; 58(6): 932-941, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32376060
6.
A retrospective analysis of efficacy and safety of adding bevacizumab to chemotherapy as first- and second-line therapy in advanced non-small-cell lung cancer (NSCLC).
Tumour Biol
; 37(8): 11479-84, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27012553
7.
A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.
Tumour Biol
; 36(1): 337-43, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25256672
8.
The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.
Tumour Biol
; 36(5): 3389-97, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25527156
9.
Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.
Chin J Cancer
; 34(4): 177-83, 2015 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25963410
10.
Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumors.
Future Oncol
; 10(16): 2579-91, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25531046
11.
Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial.
Support Care Cancer
; 22(4): 979-87, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24276953
12.
The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer.
Chin J Cancer
; 33(2): 105-14, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23816558
13.
Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: Data from literature review and a real-world analysis.
Thorac Cancer
; 15(13): 1072-1081, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532546
14.
PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer.
Transl Lung Cancer Res
; 13(2): 345-354, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38496687
15.
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor.
J Cancer Res Clin Oncol
; 149(11): 8663-8671, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37115272
16.
Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells.
J Cell Biochem
; 113(5): 1501-13, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22173954
17.
Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy.
Anticancer Drugs
; 23(5): 534-42, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22481060
18.
Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma.
Chin J Cancer
; 31(10): 476-83, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22692073
19.
SPARC expression and prognostic value in non-small cell lung cancer.
Chin J Cancer
; 31(11): 541-8, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23114088
20.
A phase II study of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer.
Thorac Cancer
; 13(10): 1463-1470, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35388976